- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-02-0063383

Resilio Pharmaceuticals Private Limited
About Resilio Pharmaceuticals Private Limited
Data last updated:
Resilio Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 11 July 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U74999TG2018PTC125588. Its GSTIN is 36AAJCR0420M1ZC (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Khaja Rahmath Ali and Sudheer Kumar Bashetty.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1 – 5 – 26/2/1 Maruthi Nagar Kothapet, Hyderabad, Telangana, India – 500060.
As per the financials filed for FY 2024, the company reported a revenue of ₹62.1 Lakh, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹2.24 Lakh (net margin 3.6%) and EBITDA of ₹4.58 Lakh (EBITDA margin 7.4%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 27% over five years.
Resilio Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0063383).
Company details
Recognitions & Rankings of Resilio Pharmaceuticals
Contact details
Resilio Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address1 – 5 – 26/2/1 Maruthi Nagar Kothapet, Hyderabad, Telangana, India – 500060
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Resilio Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Resilio Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Resilio Pharmaceuticals Private Limited, buy the company report.
Financials of Resilio Pharmaceuticals Private Limited
FY 2025 filings availableResilio Pharmaceuticals Private Limited reported revenue of ₹62.1 Lakh (up 10% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 27% over five years, including 10% growth in the latest year. EBITDA rose 39% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.58 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.24 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.4% | ||||
| Net Profit Margin | 3.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Resilio Pharmaceuticals Private Limited, buy the company report.
Board of directors of Resilio Pharmaceuticals Private Limited
Resilio Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Khaja Rahmath Ali | Director | 11 Jul 2018 | 8 Years 4 Months | Current |
| Sudheer Kumar Bashetty | Director | 11 Jul 2018 | 8 Years 4 Months | Current |
Peer comparison
Resilio Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aaiva Life Care Private Limited | ₹62.21 Lakh (FY 2025) | 19.0% | Delhi, India | |||
| Mezon Pharmaceuticals Private Limited | ₹62.12 Lakh (FY 2024) | -16.0% | Ludhiana, Punjab, India | |||
| Kaansla Pharmaceuticals Private Limited | ₹62.11 Lakh (FY 2025) | 58.0% | Panchkula, Haryana, India | |||
| Resilio Pharmaceuticals Private Limitedthis company | ₹62.1 Lakh (FY 2024) | ₹2.24 Lakh | 3.6% | 10.0% | Hyderabad, Telangana, India | |
| Meracus Pharmaceuticals Private Limited | ₹62 Lakh (FY 2024) | 31.0% | Kolkata, West Bengal, India | |||
| Avinatural Herbal Private Limited | ₹61.93 Lakh (FY 2024) | -25.0% | Delhi, India |
To see the full peer comparison of Resilio Pharmaceuticals Private Limited, buy the company report.
Auditor
Resilio Pharmaceuticals Private Limited is audited by RAJU SINGHVI & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJU SINGHVI & CO | FY 2020 | 015432S |
Shareholding
The shareholding of Resilio Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Resilio Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Resilio Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Resilio Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Resilio Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAJCR0420M1ZC | Telangana | Active | 30 Jul 2018 |
To see the full GST registrations and return filing status of Resilio Pharmaceuticals Private Limited, buy the company report.
Recent activity
Resilio Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Khaja Rahmath Ali was appointed as Director on 11 Jul 2018.
Frequently asked questions
Resilio Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 11 July 2018 (8+ years old) and is registered under CIN U74999TG2018PTC125588.
Resilio Pharmaceuticals has 2 current directors:
- Khaja Rahmath Ali - Director
- Sudheer Kumar Bashetty - Director
The latest financial statements of Resilio Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Resilio Pharmaceuticals is 36AAJCR0420M1ZC, registered in Telangana.
The CIN (Corporate Identification Number) of Resilio Pharmaceuticals is U74999TG2018PTC125588. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Resilio Pharmaceuticals was incorporated on 11 July 2018, making it 8+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Resilio Pharmaceuticals by revenue are Aaiva Life Care Private Limited, Mezon Pharmaceuticals Private Limited, Kaansla Pharmaceuticals Private Limited, Meracus Pharmaceuticals Private Limited, Avinatural Herbal Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Khaja Rahmath Ali was appointed as Director on 11 Jul 2018. Sudheer Kumar Bashetty was appointed as Director on 11 Jul 2018.
Yes, Resilio Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0063383).
The registered office of Resilio Pharmaceuticals is at 1 – 5 – 2621 Maruthi Nagar Kothapet, Hyderabad, Telangana, India – 500060.
Resilio Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

